+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatitis E Drug"

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 38 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Hepatitis E is a viral infection that affects the liver and is caused by the hepatitis E virus (HEV). Infectious Diseases Drugs are used to treat this virus and its associated symptoms. These drugs are typically antiviral medications, which work by inhibiting the replication of the virus in the body. In addition, some drugs may be used to reduce inflammation and improve liver function. The Hepatitis E Drug market is composed of a variety of pharmaceutical companies that produce and market drugs to treat the virus. These companies include Gilead Sciences, Merck & Co., Bristol-Myers Squibb, and AbbVie. Other companies involved in the market include GlaxoSmithKline, Pfizer, and Johnson & Johnson. These companies are involved in the research, development, and marketing of drugs to treat hepatitis E. Show Less Read more